
Future of Health
Strategy& has analyzed how BioPharma companies must reinvent their business models to succeed in the emerging LIFEcare ecosystem.
Strategy& has analyzed how BioPharma companies must reinvent their business models to succeed in the emerging LIFEcare ecosystem.
Strategy& has analyzed how the FiDA Regulation can catalyze growth in the Embedded Insurance sector, driving market leadership and new revenue streams.
Strategy& and PwC Autofacts® have analyzed electric vehicle sales worldwide in the first quarter of 2025.
Strategy& has analyzed the evolution of retail investor sentiment and emerging crypto trends in the digital asset market.
The family-led technology firm reinvents itself to offer global intelligent mobility solutions for 21st century traffic challenges working with Strategy&.
Our client, the European arm of a global highly engineered products company, was facing challenging external conditions.
After decades of acquisitions, how did one company make a smart bet on divestiture?
As part of the PwC network, Strategy& helps clients solve their issues from strategy through to execution. We do that by combining our strategy consulting expertise with the vast capabilities of the network, to help you move your business forward with confidence.